<DOC>
	<DOCNO>NCT00180635</DOCNO>
	<brief_summary>The primary aim study investigate effect oral inhaled administration L-arginine inhale aminoguanidine bronchial alveolar exhale NO NO metabolites exhale breath condensate , induced sputum , nasal lavage mouth wash fluid healthy non-smokers , current smoker patient COPD .</brief_summary>
	<brief_title>NO Donors Inhibitors Study Imbalance Nitrogen Stress Antioxidant Defense COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>Pimagedine</mesh_term>
	<criteria>Healthy nonsmoker Normal spirometry ( FEV1 &gt; 90 % predict ; exhale NO big equal 10 ppb ; flow 50 ml/s ) At risk ( current smoker ) Normal spirometry , without chronic symptom ( cough , sputum production ) FEV1 reversibility &lt; 15 % inhaled beta2agonists* Moderate COPD FEV1 great equal 30 % &lt; 80 % FEV1/FVC &lt; 70 % predict FEV1 reversibility &lt; 15 % inhaled beta2agonists With without chronic symptom ( cough , sputum production , dyspnea ) Able comprehend grant write informed consent Concomitant use pretreatment within last 4 week oral steroid Respiratory infection within 4 week prior entry trial Females pregnant lactate History current past drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>